Related Experiment Video
Updated: Nov 22, 2025

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
Targeting T-type/CaV3.2 channels for chronic pain
Song Cai1, Kimberly Gomez2, Aubin Moutal2
1Department of Anatomy, Histology & Developmental Biology, School of Basic Medical Sciences, Shenzhen University Health Science Centre, Shenzhen, Guangdong Province, PR China.
Abstract:
T-type calcium channels regulate neuronal excitability and are important contributors of pain processing. CaV3.2 channels are the major isoform expressed in nonpeptidergic and peptidergic nociceptive neurons and are emerging as promising targets for pain treatment. Numerous studies have shown that CaV3.2 expression and/or activity are significantly increased in spinal dorsal horn and in dorsal root ganglia neurons in different inflammatory and neuropathic pain models. Pharmacological campaigns to inhibit the functional expression of CaV3.2 for treatment of pain have focused on the development of direct channel blockers, but none have produced lead candidates. Targeting the proteins that regulate the trafficking or transcription, and the ones that modify the channels via post-translational modifications are alternative means to regulate expression and function of CaV3.2 channels and hence to develop new drugs to control pain. Here we synthesize data supporting a role for CaV3.2 in numerous pain modalities and then discuss emerging opportunities for the indirect targeting of CaV3.2 channels.
Insights
T-type calcium channels, specifically CaV3.2, are key in pain processing. Indirectly targeting these channels offers new therapeutic strategies for pain management, overcoming limitations of direct blockers.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- T-type calcium channels regulate neuronal excitability and pain.
- CaV3.2 channels are crucial in nociceptive neurons and implicated in pain models.
- Increased CaV3.2 expression/activity is observed in inflammatory and neuropathic pain.
Purpose of the Study:
- To review the role of CaV3.2 channels in various pain modalities.
- To explore alternative strategies for targeting CaV3.2 channels for pain treatment.
- To discuss emerging opportunities for indirect CaV3.2 channel modulation.
Main Methods:
- Literature synthesis of studies on CaV3.2 channels in pain.
- Analysis of data supporting CaV3.2 involvement in pain processing.
- Discussion of indirect targeting approaches (trafficking, transcription, post-translational modifications).
Main Results:
- CaV3.2 channels play a significant role in multiple pain types.
- Direct blockers of CaV3.2 have not yielded successful drug candidates.
- Indirect modulation offers a promising alternative for therapeutic intervention.
Conclusions:
- CaV3.2 channels are validated targets for pain relief.
- Indirect targeting strategies present novel avenues for drug development.
- Further research into indirect CaV3.2 modulation could lead to effective pain therapies.
Related Concept Videos
Analgesia and Pain Management
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Mechanically-gated Ion Channels

